Net Cash Provided by (Used in) Operating Activities |
-1.41M |
USD |
-147% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
176K |
USD |
-97.9% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
213K |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
8.6M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.3M |
USD |
+37.2% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
924K |
USD |
+7.32% |
Q2 2023 |
FY 2023 |
Depreciation |
53K |
USD |
-10.2% |
Q3 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
2K |
USD |
-90.5% |
Q3 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.09M |
USD |
-536% |
Q3 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
10.6M |
USD |
+0.63% |
Q2 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
-27K |
USD |
+70.3% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
500K |
shares |
0% |
Q3 2024 |
Q1 2025 |
Unrecognized Tax Benefits |
565K |
USD |
+31.4% |
Q3 2023 |
Q1 2024 |
Additional Paid in Capital |
34.9M |
USD |
0% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
137K |
USD |
0% |
Q3 2024 |
Q1 2025 |
Interest Expense |
8.34M |
USD |
+207% |
Q1 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |